Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Darren Brenner, MD
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Neal Shore, MD, FACS
Sarah Psutka, MD, MS
What’s New In Glaucoma?
Paul Petrakos, DO, MS
Justin Schweitzer, OD, FAAO
I. Paul Singh, MD
Sarah H. Van Tassel, MD
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Kendall Moseley, MD
Kenneth G. Saag, MD
Trial in Progress: Phase 3 MoonRISe-3 Study
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Ocular to Generalized MG: How and Why the Disease Evolves
Hans Katzberg, MD
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Nicholas J. Silvestri, MD
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Diagnostic Advances in gMG: Effective Tools and Techniques
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Robert D. Suh, MD
Lea Azour, MD
Ashwin Basavaraj, MD
Acromegaly Care: Individualized Diagnosis and Management Strategies
July 13, 2025
San Francisco, California
New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Managing Side Effects in FcRn Therapy: Best Practices for gMG
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
What’s New in Subconjunctival MIBS
What’s New in Glaucoma Topical Therapies?
New Solutions for Optimizing IOP Control: A Case-Based Approach
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.